Rectal metastasis in Lung cancer: A case report and review of the literature
Nội dung chính của bài viết
Tóm tắt
Gastrointestinal metastasis in lung cancer is not commonly encountered clinically, of which rectal involvement is a sporadic event. There were few reports about rectal metastasis in lung cancer. All of them had a dismal prognosis. We report a case of synchronous rectal metastasis in a lung cancer patient with a different clinical scenario, treatment, and prognosis. The patient presented with infrequent hematochezia due to a rectal mass confirmed as adenocarcinoma on core biopsy. Computer tomography showed many nodules in both lungs, which raised the initial diagnosis of pulmonary metastasis in rectal cancer. However, we decided to perform immunohistochemistry on the rectal biopsy specimen, which, surprisingly, revealed the site of origin was from the lung. Subsequently, next gene sequencing was performed and detected an exon 19 deletion on the EGFR gene. Though he had infrequent hematochezia, we decided to treat him with Erlotinib (a first-generation TKI) and closely monitored the rectal symptoms. Six months later, he achieved a complete response of both lung and rectal lesions. At present, he has been progression-free for 14 months. Thus, physicians should always be aware of this differential diagnosis in synchronous tumors and carefully consider the optimal treatment to start.
Chi tiết bài viết
Từ khóa
rectal metastases, lung cancer, TKI
Tài liệu tham khảo
2. Rossi G, Marchioni A, Romagnani E, et al. Primary lung cancer presenting with gastrointestinal tract involvement: clinicopathologic and immunohistochemical features in a series of 18 consecutive cases. J Thorac Oncol. 2007;2(2):115-120.
3. Cedrés S, Mulet-Margalef N, Montero MA, et al. Rectal Metastases from Squamous Cell Carcinoma: A Case Report and Review of the Literature. Case Reports in Medicine. 2012;2012:e947524.
4. Rama N, Monteiro A, Bernardo JE, et al. Lung metastases from colorectal cancer: surgical resection and prognostic factors. European Journal of Cardio-Thoracic Surgery. 2009;35(3):444-449.
5. Pulmonary metastases. Radiology Reference. Radiopaedia.org. Accessed September 10, 2021. https://radiopaedia.org/articles/pulmonary-metastases.
6. Taira N, Kawabata T, Gabe A, et al. Analysis of gastrointestinal metastasis of primary lung cancer: Clinical characteristics and prognosis. Oncol Lett. 2017;14(2):2399-2404.
7. Hu Y, Feit N, Huang Y, et al. Gastrointestinal metastasis of primary lung cancer: An analysis of 366 cases. Oncology letters. 2018;15(6).
8. Jevremovic V. Is Gastrointestinal Metastasis of Primary Lung Malignancy as Rare as Reported in the Literature? A Comparison Between Clinical Cases and Post-mortem Studies. Oncol Hematol Rev. 2016;12(01):51-57.
9. Katsinelos P, Paroutoglou G, Beltsis A, et al. Hematemesis as a presenting symptom of lung cancer with synchronous metastases to the esophagus and stomach. A case report. Rom J Gastroenterol. 2004;13(3):251-253.
10. Lu B, Ding C, Wang C, Cao J. A case of small intestinal hemorrhage secondary to metastatic lung cancer in the elderly. Chin J Cancer Res. 2015;27(2):218-220.
11. Moldvay J, Jackel M, Bogos K, et al. The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas. Pathol Oncol Res. 2004;10(2):85-88.
12. Saad RS, Ghorab Z, Khalifa MA, et al. CDX2 as a marker for intestinal differentiation: Its utility and limitations. World J Gastrointest Surg. 2011;3(11):159-166.
13. Wu TH, Hsiue EH, Lee JH, et al. Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non-Small-cell Lung Cancer Patients. Clin Lung Cancer. 2018;19(3):361-372.
14. Takeda M, Okamoto I, Nakagawa K. Survival outcome assessed according to tumor response and shrinkage pattern in patients with EGFR mutation-positive non-small-cell lung cancer treated with gefitinib or erlotinib. J Thorac Oncol. 2014;9(2):200-204.